APA (7th ed.) Citation

KE, S., B, J., CS, T., R, Z., SR, W., CP, R., . . . DH, B. (2021). Safety, pharmacokinetics and antiviral activity of PGT121, a broadly neutralizing monoclonal antibody against HIV-1: A randomized, placebo-controlled, phase 1 clinical trial. Nature medicine, 27(10), 1718. https://doi.org/10.1038/s41591-021-01509-0

Chicago Style (17th ed.) Citation

KE, Stephenson, et al. "Safety, Pharmacokinetics and Antiviral Activity of PGT121, a Broadly Neutralizing Monoclonal Antibody Against HIV-1: A Randomized, Placebo-controlled, Phase 1 Clinical Trial." Nature Medicine 27, no. 10 (2021): 1718. https://doi.org/10.1038/s41591-021-01509-0.

MLA (9th ed.) Citation

KE, Stephenson, et al. "Safety, Pharmacokinetics and Antiviral Activity of PGT121, a Broadly Neutralizing Monoclonal Antibody Against HIV-1: A Randomized, Placebo-controlled, Phase 1 Clinical Trial." Nature Medicine, vol. 27, no. 10, 2021, p. 1718, https://doi.org/10.1038/s41591-021-01509-0.